These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29191570)

  • 21. Investigating the causal effect of cannabis use on cognitive function with a quasi-experimental co-twin design.
    Ross JM; Ellingson JM; Rhee SH; Hewitt JK; Corley RP; Lessem JM; Friedman NP
    Drug Alcohol Depend; 2020 Jan; 206():107712. PubMed ID: 31753729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Executive function deficits in short-term abstinent cannabis users.
    McHale S; Hunt N
    Hum Psychopharmacol; 2008 Jul; 23(5):409-15. PubMed ID: 18421794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users.
    Weinstein A; Livny A; Weizman A
    Curr Pharm Des; 2016; 22(42):6366-6379. PubMed ID: 27549374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse Effects of Cannabis Use on Neurocognitive Functioning: A Systematic Review of Meta- Analytic Studies.
    Duperrouzel JC; Granja K; Pacheco-Colón I; Gonzalez R
    J Dual Diagn; 2020; 16(1):43-57. PubMed ID: 31232216
    [No Abstract]   [Full Text] [Related]  

  • 25. Cannabis and cocaine decrease cognitive impulse control and functional corticostriatal connectivity in drug users with low activity DBH genotypes.
    Ramaekers JG; van Wel JH; Spronk D; Franke B; Kenis G; Toennes SW; Kuypers KP; Theunissen EL; Stiers P; Verkes RJ
    Brain Imaging Behav; 2016 Dec; 10(4):1254-1263. PubMed ID: 26667034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabis and a lower BMI in psychosis: What is the role of AKT1?
    Liemburg EJ; Bruins J; van Beveren N; Islam MA; Alizadeh BZ;
    Schizophr Res; 2016 Oct; 176(2-3):95-99. PubMed ID: 27554198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
    Indlekofer F; Piechatzek M; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
    J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.
    Schilt T; de Win MM; Koeter M; Jager G; Korf DJ; van den Brink W; Schmand B
    Arch Gen Psychiatry; 2007 Jun; 64(6):728-36. PubMed ID: 17548754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurocognitive and social cognitive predictors of cannabis use in first-episode psychosis.
    Arnold C; Allott K; Farhall J; Killackey E; Cotton S
    Schizophr Res; 2015 Oct; 168(1-2):231-7. PubMed ID: 26260081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A biosocial cognitive model of cannabis use in emerging adulthood.
    Papinczak ZE; Connor JP; Harnett P; Gullo MJ
    Addict Behav; 2018 Jan; 76():229-235. PubMed ID: 28863315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catechol-O-Methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis: clinical-onset implications.
    Pelayo-Terán JM; Pérez-Iglesias R; Mata I; Carrasco-Marín E; Vázquez-Barquero JL; Crespo-Facorro B
    Psychiatry Res; 2010 Oct; 179(3):291-6. PubMed ID: 20493536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder.
    Ringen PA; Melle I; Berg AO; Agartz I; Spigset O; Simonsen C; Sundet K; Andreassen OA
    Schizophr Res; 2013 Jan; 143(1):84-9. PubMed ID: 23178107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism.
    Estrada G; Fatjó-Vilas M; Muñoz MJ; Pulido G; Miñano MJ; Toledo E; Illa JM; Martín M; Miralles ML; Miret S; Campanera S; Bernabeu C; Navarro ME; Fañanás L
    Acta Psychiatr Scand; 2011 Jun; 123(6):485-92. PubMed ID: 21231925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes.
    Alemany S; Arias B; Fatjó-Vilas M; Villa H; Moya J; Ibáñez MI; Ortet G; Gastó C; Fañanás L
    Acta Psychiatr Scand; 2014 Jan; 129(1):54-62. PubMed ID: 23445265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurocognitive consequences of marihuana--a comparison with pre-drug performance.
    Fried PA; Watkinson B; Gray R
    Neurotoxicol Teratol; 2005; 27(2):231-9. PubMed ID: 15734274
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Lisdahl KM; Wright NE; Kirchner-Medina C; Maple KE; Shollenbarger S
    Curr Addict Rep; 2014 Jun; 1(2):144-156. PubMed ID: 25013751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetic-guided cannabis usage in the community pharmacy: evaluation of a pilot program.
    Papastergiou J; Li W; Sterling C; van den Bemt B
    J Cannabis Res; 2020 Sep; 2(1):24. PubMed ID: 33526106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabis and tolerance: acute drug impairment as a function of cannabis use history.
    Ramaekers JG; van Wel JH; Spronk DB; Toennes SW; Kuypers KP; Theunissen EL; Verkes RJ
    Sci Rep; 2016 May; 6():26843. PubMed ID: 27225696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.
    Ramaekers JG; Kauert G; Theunissen EL; Toennes SW; Moeller MR
    J Psychopharmacol; 2009 May; 23(3):266-77. PubMed ID: 18719045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.